دورية أكاديمية
The relationship between 25-hydroxy vitamin D and serum asprosin in patients with type 2 diabetes in the community.
| العنوان: | The relationship between 25-hydroxy vitamin D and serum asprosin in patients with type 2 diabetes in the community. |
|---|---|
| المؤلفون: | Cui J; Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China.; First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China., Wang Z; First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China., Yin J; Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China., Li M; Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China., Wu Q; Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China., Liu M; Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China., Su H; Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China., Ren H; Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China., Xu M; Department of Endocrinology, Changzhi Second People's Hospital, Changzhi, Shanxi, China., Yang J; Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China., Xu L; Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China.; Shanxi Innovation Center for Integrated Management of Hypertension, Hyperlipidemia and Hyperglycemia Correlated with Cardiovascular and Cerebrovascular Diseases, Taiyuan, Shanxi, China. |
| المصدر: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Jul 31; Vol. 15, pp. 1409156. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Research Foundation] |
| مواضيع طبية MeSH: | Diabetes Mellitus, Type 2*/blood , Diabetes Mellitus, Type 2*/epidemiology , Vitamin D*/blood , Vitamin D*/analogs & derivatives , Fibrillin-1*/blood, Humans ; Female ; Male ; Middle Aged ; Aged ; Biomarkers/blood ; Adult ; Adipokines |
| مستخلص: | Objectives: This study aimed to investigate the link between 25-hydroxy vitamin D and serum asprosin in individuals with type 2 diabetes within the community. The goal was to provide a foundation for clinical interventions. Methods: Between November 2019 and July 2021, data from 463 patients with type 2 diabetes were consistently gathered at a community health service station in Southeast Shanxi Province. General information and laboratory metrics were compiled, including serum asprosin levels. The participants were categorized based on three serum asprosin quantiles, allowing for a comparison of various factors among the groups. The correlation between serum asprosin levels and other factors was analyzed. Employing a general linear model, the connection between 25-hydroxy vitamin D and serum asprosin levels was studied. Utilizing three quantiles of 25-hydroxy vitamin D, serum asprosin was treated as the dependent variable, while 25-hydroxy vitamin D served as the independent variable for linear regression analysis. Results: As serum asprosin increased, there were gradual increments in age, disease duration, SBP, BMI, WC, creatinine, and SUA levels (P<0.05). Conversely, HbA1c, HDL-C, GFR, and 25-hydroxy vitamin D levels exhibited gradual declines (P<0.05). Age, 25-hydroxy vitamin D, SUA, creatinine, and LDL-C emerged as independent influencing factors for serum asprosin. Across the 1st to 3rd 25-hydroxy vitamin D quantiles, elevated 25-hydroxy vitamin D levels correlated with a gradual reduction in mean serum asprosin (P<0.05). Conclusion: Serum asprosin levels demonstrate an inverse correlation with 25-hydroxy vitamin D levels in community-dwelling individuals with type 2 diabetes. Serum asprosin levels might independently contribute to 25-hydroxy vitamin D levels. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 Cui, Wang, Yin, Li, Wu, Liu, Su, Ren, Xu, Yang and Xu.) |
| References: | Eur J Endocrinol. 2009 Jun;160(6):965-71. (PMID: 19289535) Endocrine. 2010 Oct;38(2):235-42. (PMID: 21046484) Clin Chim Acta. 2019 Feb;489:183-188. (PMID: 29104036) Mediators Inflamm. 2018 Mar 20;2018:9471583. (PMID: 29743813) J Diabetes Res. 2015;2015:636891. (PMID: 25741510) J Allergy Clin Immunol. 2005 May;115(5):911-9; quiz 920. (PMID: 15867843) Diabetes. 2009 Apr;58(4):773-95. (PMID: 19336687) Cell. 2016 Apr 21;165(3):566-79. (PMID: 27087445) J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):122-6. (PMID: 18840526) Diabetes Care. 2010 Sep;33(9):2021-3. (PMID: 20805275) J Endocrinol. 2013 Jan 02;216(1):T1-T15. (PMID: 23160966) J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56. (PMID: 15181022) Diabetes Metab Syndr Obes. 2022 Jun 18;15:1877-1884. (PMID: 35757196) J Endocrinol Invest. 2013 Jan;36(1):1-6. (PMID: 22183134) Diabetol Metab Syndr. 2021 May 1;13(1):51. (PMID: 33933135) J Clin Med. 2019 May 12;8(5):. (PMID: 31083617) Int J Mol Sci. 2020 Sep 11;21(18):. (PMID: 32932777) J Cell Biochem. 2011 Nov;112(11):3393-405. (PMID: 21769914) Mediators Inflamm. 2018 Nov 6;2018:7375294. (PMID: 30524197) J Clin Med. 2021 May 28;10(11):. (PMID: 34071365) Nat Med. 2017 Dec;23(12):1444-1453. (PMID: 29106398) Nat Med. 2017 Jul 11;23(7):804-814. (PMID: 28697184) |
| فهرسة مساهمة: | Keywords: 25-hydroxy vitamin D; asprosin; community; diabetes; insulin resistance; type 2 |
| المشرفين على المادة: | 1406-16-2 (Vitamin D) A288AR3C9H (25-hydroxyvitamin D) 0 (Fibrillin-1) 0 (FBN1 protein, human) 0 (Biomarkers) 0 (Adipokines) |
| تواريخ الأحداث: | Date Created: 20240815 Date Completed: 20240815 Latest Revision: 20240816 |
| رمز التحديث: | 20240816 |
| مُعرف محوري في PubMed: | PMC11322110 |
| DOI: | 10.3389/fendo.2024.1409156 |
| PMID: | 39145312 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2024.1409156 |